|

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

RECRUITINGSponsored by University of Minnesota
Actively Recruiting
SponsorUniversity of Minnesota
Started2025-06-30
Est. completion2027-06-30
Eligibility
Age18 Years+
Locations1 site

Summary

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Eligibility

Age: 18 Years+
Inclusion Criteria:

* 18 years and older
* Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent
* Able to understand, speak, read, and write in English
* Patients who have undergone hysterectomy, or plan to have a hysterectomy
* Patients who are transgender and gender diverse"

Exclusion Criteria:

* Opted out of research
* \<18 years old
* Lacks capacity to consent/has diminished capacity to consent
* Cannot provide informed consent
* Those on the study's community advisory board

Conditions4

CancerCancer ScreeningGender Diverse PopulationsTransgender

Locations1 site

University of Minnesota
Minneota, Minnesota, 55455
Maria Bunch612-624-2018obgynresearch@umn.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.